-
Product Insights
Per Pedersen – Nyborg Residential Community – South Denmark
The Per Pedersen – Nyborg Residential Community – South Denmark project involves the construction of a residential community comprising 122 homes ranging from 67m2 to 111m2 on Hyrdegyden in Nyborg, Denmark. Equip yourself with the essential tools needed to make informed and profitable decisions with our Per Pedersen – Nyborg Residential Community – South Denmark report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of...
-
Company Insights
Innovation and Patenting activity of Per Aarsleff Holding AS Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Per Aarsleff Holding AS Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PER-001 in Diabetic Retinopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PER-001 in Diabetic Retinopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PER-001 in Diabetic Retinopathy Drug Details: PER-001 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PER-001 in Open-Angle Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PER-001 in Open-Angle Glaucoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PER-001 in Open-Angle Glaucoma Drug Details: PER-001 is under development for the...
-
Product Insights
NewLikelihood of Approval Analysis for Ocular Melanoma
Overview How likely is it that the drugs in Ocular Melanoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ocular Melanoma Overview Ocular melanoma is an extremely rare form of cancer...
-
Product Insights
NewLikelihood of Approval Analysis for Asthma
Overview How likely is it that the drugs in Asthma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Asthma Overview Asthma is a long-term inflammatory disease of the airways of the...
-
Product Insights
NewLikelihood of Approval Analysis for Mesenchymal Tumor Of The Gastrointestinal Tract
Overview How likely is it that the drugs in Mesenchymal Tumor Of The Gastrointestinal Tract will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mesenchymal Tumor Of The Gastrointestinal Tract Overview Mesenchymal...
-
Analyst Opinions
NewOil and Gas Sector Strategies in Electric Vehicles
Oil and Gas Sector Strategies in EV Report Overview As the world races to meet net zero targets, both public and private sectors are having to find alternative solutions and invest in innovative technologies. The transportation sector accounts for a significant portion of the global energy use, leading to a hunt for alternative fuel solutions for sustainable mobility. A type of alternative fuel vehicle that has been growing rapidly is battery electric vehicles (BEVs), also referred to as EVs. The...
-
Macroeconomic Analysis
NewVenezuela PESTLE Insights – A Macroeconomic Outlook Report
Mining, manufacturing and utilities activities contributed 45.9% to the gross value added (GVA) in 2023, followed by wholesale, retail and hotels (24.1%), and construction activities (2.4%), according to GlobalData estimates. According to OPEC, Venezuela has around 303.2 billion barrels of proven crude oil reserves, it produced 716,000 barrels of crude oil per day in 2022.
-
Sector Analysis
NewAmericas Food Market Opportunities, Trends, Growth Analysis and Forecast to 2028
Americas Food Market Overview The Americas food market was valued at $1.28 trillion in 2023. The Americas was the second-largest market in the global food industry in 2023 and will garner a CAGR of more than 4% during 2023-2028. Americas Food Market Outlook 2023-2028 ($ Trillion) Buy the Full Report for more Insights on the Americas Food Market Forecast, Download a Free Sample The Americas food market report provides an overview of the current food industry scenario regarding the outlook...